Drug Side Effects
Search
PORTAL VEIN CAVERNOUS TRANSFORMATION
PORTAL VEIN CAVERNOUS TRANSFORMATION
was reported 41 times
PORTAL VEIN CAVERNOUS TRANSFORMATION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Anthelmintic [EPC]
1
0.0003
1
Androgen [EPC]
6
0.0002
2
Oxazolidinone Antibacterial [EPC]
6
0.0002
3
Dipeptidyl Peptidase 4 Inhibitor [EPC]
6
0.0002
4
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
1
0.0001
5
BCL-2 Inhibitor [EPC]
6
0.0001
6
Parenteral Iron Replacement [EPC]
1
0.0001
7
Complement Inhibitor [EPC]
3
0.0001
8
Iron Chelator [EPC]
1
0.0000
9
Nucleoside Metabolic Inhibitor [EPC]
6
0.0000
10
Leukocyte Growth Factor [EPC]
3
0.0000
11
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
12
Vitamin D [EPC]
6
0.0000
13
Vitamin B12 [EPC]
6
0.0000
14
Vitamin C [EPC]
6
0.0000
15
Vascular Endothelial Growth Factor Inhibitor [EPC]
2
0.0000
16
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
17
Atypical Antipsychotic [EPC]
4
0.0000
18
Aldosterone Antagonist [EPC]
1
0.0000
19
Dihydropyridine Calcium Channel Blocker [EPC]
2
0.0000
20
Estrogen [EPC]
1
0.0000
21
Factor Xa Inhibitor [EPC]
1
0.0000
22
Platelet Aggregation Inhibitor [EPC]
2
0.0000
23
Progestin [EPC]
1
0.0000
24
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000
25
Tumor Necrosis Factor Blocker [EPC]
1
0.0000
26
Corticosteroid [EPC]
1
0.0000